December 19, 2012

OraSure to Pay New Federal Tax on Medical Devices

The makers of the first rapid over-the-counter test for HIV are subject to a 2.3 percent excise tax on gross sales of some of its products starting in 2013, The Morning Call reports. To help pay for the expansion of health care coverage to 30 million previously uninsured people, the Affordable Care Act (a.k.a. the health care reform law) imposes this tax on many medical device manufacturers, such as OraSure Technologies, which manufactures the OraQuick In-Home HIV Test. Through 2022, the federal government estimates raising $29 billion in revenues from this tax.

To read the article, click here.

Search: OraSure, OraQuick, Affordable Care Act, ACA, health care reform, tax

Scroll down to comment on this story.

Previous Comments:

Michael, Norfolk, 2013-01-03 13:39:21
Of course the govt wants to make,money how much if that 29 billion through 2022 will be used in hiv care less than 1%

Frederick Wright, Coach valley, 2012-12-20 12:45:37
Happy am I today and thank God that these government contracted venders or set a side medical devices are returning some of their profits or wealth from American funded healthcare dollars. I like to think of this as a lobbying tax. In the case of Oral Sure a government bonded start up company justifies an opportunity to pay back our communities directly to ensure more government contracts for their future company's growth.Yes ,we'll done,in an attempt to create Fair &. Free competitive market